Full Text
Drugs for Rare (And Ultra-Rare) Diseases in Europe- Analysis of Budget Impact and Cost Drivers

Abstract

Authors

M Schlander K Stenner A Gandjour

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×